Core Viewpoint - Sharp Therapeutics Corp. is initiating a non-brokered private placement of unsecured convertible notes totaling up to US$3.0 million, with the aim of using the proceeds for general working capital purposes [1]. Group 1: Note Offering Details - The proposed Note Offering will consist of notes with a principal amount of US$1,000 each, convertible into common shares at a price of US$2.00 per share [2]. - Each note will bear an interest rate of 6.0% per annum, calculated as simple interest and payable in cash on the maturity date [3]. - The notes will convert into common shares if the company completes an equity financing of at least US$7,000,000 prior to the maturity date, with a 20-day notice to note holders [4]. Group 2: Participation and Commitments - STX Partners, LLC and other insiders have confirmed their intention to participate in the Note Offering [5]. - The company previously announced a common share offering at US$2.50 per share, expected to close in the first quarter of 2026, with proceeds also aimed at general working capital [6]. - STX, the largest shareholder, has committed to purchase at least 1,600,000 common shares, contingent upon raising at least US$6,000,000 from other investors [7]. Group 3: Regulatory and Offering Conditions - The offerings will be conducted as private placements under Canadian securities laws and may also be offered in the U.S. under applicable exemptions [9]. - All issued notes and common shares will be subject to a four-month hold period and require approval from the TSX Venture Exchange [10]. - The insider participation in the offerings is classified as a related-party transaction, exempt from formal valuation or minority shareholder approval due to the market capitalization criteria [8]. Group 4: Company Overview - Sharp Therapeutics is a preclinical-stage company focused on developing small-molecule therapeutics for genetic diseases, utilizing a discovery platform that combines high throughput screening technologies [11].

Summary of Vizsla Silver's Feasibility Study and Convertible Notes Offering Company Overview - **Company**: Vizsla Silver - **Industry**: Silver and Gold Mining - **Project**: Panuco Mine in Mexico Key Points from the Feasibility Study - **Feasibility Study Significance**: The study positions Panuco as a tier-one asset of global significance, with plans to become a leading silver and gold producer globally [2][3] - **Production Goals**: Internal goal to reach 50 million ounces of production in the next 10 years, primarily from the Panuco mine [3] - **Financial Metrics**: - Post-tax NPV of $1.8 billion - Post-tax IRR of 111% - Initial capital cost of $238.7 million - NPV to CapEx ratio of 7.5 times [22][49] - **Production Estimates**: - Average payable silver equivalent production of 20.1 million ounces over the first five years - Life of mine production of 17.4 million ounces per annum [22][24] - **Cost Structure**: - All-in sustaining cost of $10.61 per ounce - Operating cost of $85.11 per ton milled [24][46] Financing Details - **Bond Issuance**: Closing of a $300 million bond issuance, the largest in the silver industry, fully financing the Panuco project [5][12] - **Financial Flexibility**: The bond can be settled in cash, stock, or a combination, allowing for flexibility without diluting equity [6][10] - **Comparison to Previous Financing**: The bond replaces a previously announced Macquarie facility, providing lower cost of capital and fewer restrictions [9][10] Project Development and Timeline - **Permit Timeline**: Expecting permits by mid-2026, with construction planned for the second half of 2026 [15][19] - **Test Mine Development**: Ongoing test mine operations to de-risk the project and prepare for production [16][56] - **Infrastructure and Community Engagement**: Strong local community ties with 70% of the workforce sourced locally and significant investments in community projects [20][19] Exploration and Growth Potential - **Land Package Expansion**: The land package has quadrupled since 2024, with less than 70% mapped and only 28% of known veins explored [17][65] - **Future Exploration Plans**: Continued exploration in the wider property, including the Lagara project and Santa Fe, with systematic exploration planned [66][63] Conclusion - **Investment Opportunity**: Vizsla Silver presents a compelling investment opportunity with robust financial metrics, a strong production profile, and significant growth potential in the silver mining sector [14][16]

Funding & Capital - BTCS Inc plans to raise up to $2 billion through ATM offerings, convertible notes, and warrants [1] Use of Proceeds - The company intends to use the net proceeds to expand ETH reserves [1] - Proceeds will also support working capital and other general corporate purposes [1]

Core Insights - Upexi, Inc. has successfully closed a private placement equity offering of 12,457,186 shares of common stock at a price of $4.00 per share, generating approximately $50 million in gross proceeds before expenses [1][2] Group 1: Equity Offering Details - The equity offering involved accredited investors, qualified purchasers, and institutional investors, including the CEO and a director of the company [1] - The shares were sold at a price of $4.00 per share, with management and board participation priced at $4.94 per share [1] - A.G.P./Alliance Global Partners acted as the sole placement agent for the offering [3] Group 2: Use of Proceeds - Proceeds from the equity offering will be used to cover placement agent fees and offering-related expenses, support general working capital needs, and advance the company's Solana treasury strategy [2] Group 3: Future Offerings - The company anticipates closing a previously disclosed $150 million convertible notes offering in exchange for Solana on or about July 16, 2025 [2]